Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

Bristol-Myers Stock: Is Wall Street Bullish or Bearish?

Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products. With a market cap of $113.5 billion, the company focuses on products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.

Shares of this biopharma giant have underperformed the broader market considerably over the past year. BMY has gained 4.7% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 35.8%. In 2024, BMY stock is up 7.7%, compared to the SPX’s 24.3% rise on a YTD basis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.